The StarClose Vascular Closure Device in Antegrade and Retrograde Punctures: A Single-Center Experience

Chiu, Albert; Coles, Simon; Tibballs, Jonathan; Nadkarni, Sanjay

doi:10.1583/09-2873.1

Cited by 20 publications

(12 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Apart from a handful of studies, reports detailing experience with the StarClose device during peripheral angioplasty procedures have been few. [8][9][10][11] Thus, we performed a retrospective study that spanned 5 years and .1000 consecutive peripheral angioplasty procedures with either retrograde or antegrade femoral artery catheterization.…”

Section: ¤ ¤mentioning

confidence: 99%

Safety and Efficacy of the StarClose Vascular Closure Device in More Than 1000 Consecutive Peripheral Angioplasty Procedures

Spiliοpoulos¹,

Κατσάνος²,

Karnabatidis³

et al. 2011

Journal of Endovascular Therapy

View full text Add to dashboard Cite

show abstract

Section: ¤ ¤mentioning

confidence: 99%

Safety and Efficacy of the StarClose Vascular Closure Device in More Than 1000 Consecutive Peripheral Angioplasty Procedures

Spiliοpoulos¹,

Κατσάνος²,

Karnabatidis³

et al. 2011

Journal of Endovascular Therapy

View full text Add to dashboard Cite

show abstract

“…An explanation might be that femoral angiography was performed to exclude severe stenosis, severe calcification, dissection, distortion or vascular malformations before IABP support procedures. In other studies [2,4,5,6,7,18,19,20,22,23,24], the StarClose device was used for hemostasis immediately after diagnostic and interventional catheterizations whereas in our study, the procedure was performed 2–7 days after IABP insertion. The elasticity of 8-Fr holes was poor, and the blood exuded easily through the puncture channel after deployment of the StarClose, which might be the reason for the higher rate of bleeding complications in our series.…”

Section: Discussionmentioning

confidence: 89%

“…Glycoprotein IIb/IIIa inhibitors were utilized in 19.0% of patients. However, the patients undergoing diagnostic catheterization only took aspirin [7,8,24]. Anticoagulation treatment was not routinely used after peripheral angioplasty procedures [6,19,20].…”

Section: Discussionmentioning

confidence: 99%

“…The StarClose Vascular Closure System has some practical advantages over the other devices, as it closes the arteriotomy without an intraluminal component. This device has been proven to not be inferior to manual compression with regard to major vascular events for the closure of 5-, 6- and 7-Fr sheaths [2,5,6,7,8,9,10,11]. Although the StarClose for closure of the 8-Fr common femoral artery (CFA) sheath access sites following peripheral vascular interventions is far beyond the approved range of arteriotomies, it appears to be effective in maintaining hemostasis in a few studies [2,3].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Safety and Efficacy of the StarClose Vascular Closure System following 8-Fr Sheath Placement for Intra-Aortic Balloon Pump: A Single-Center Analysis of 42 Consecutive Patients

Chu¹,

Yang²,

Zhang³

et al. 2014

Med Princ Pract

View full text Add to dashboard Cite

Objective: To assess the safety and efficacy of the StarClose device following intra-aortic balloon pump (IABP) counterpulsation using 8-Fr femoral sheaths. Subjects and Methods: From June 2008 to August 2012, 42 consecutive patients who received IABP implantation via common femoral artery (CFA) punctures with an 8-Fr sheath (which were then sealed with the StarClose Vascular Closure System at the bedside) were included in this retrospective single-arm study. All the patients underwent duplex control of the puncture site 24 h after deployment of the device, in order to determine the presence or absence of vascular complications including hematoma, pseudoaneurysm, arteriovenous fistula and arterial/venous thrombosis or stenosis. The safety end points were the vascular complications during the hospital stay, and the efficacy end points included device and procedure success. Results: The procedure success rate was 92.9% (39/42) and the device success rate was 88.1% (37/42). Major vascular complications occurred in 3 (7.1%) patients; 1 developed a massive hematoma >10 cm which was managed by blood transfusion and surgical reconstruction, and the other 2 developed pseudoaneurysm which was cured by ultrasound-guided thrombin injection or manual compression. Minor vascular complications occurred in 5 (11.9%) patients, including blood oozing in 2, hematoma <5 cm in 2 and severe pain in the remaining patient. Conclusion: CFA closure with the StarClose device was safe, feasible and effective in patients undergoing IABP support using 8-Fr sheath sizes.

show abstract

“…But this problem was also found in heavily calcified vessels and previous surgery. The clip-based closure system Star Close was used by Chiu et al 10 in 142 cases. In 11/142 (7.7%) patients, the system could not be successfully placed, especially with the antegrade puncture technique.…”

Section: Discussionmentioning

confidence: 99%

Percutaneous Vascular Closure System Based on an Extravascular, Bioabsorbable Polyglycolic Plug (ExoSeal): Results from 1000 Patients

Kamusella

Wissgott

Jahnke

et al. 2014

Clin Med Insights Cardiol

View full text Add to dashboard Cite

PURPOSEThe objective of this prospective study was to evaluate the effectiveness and safety of a percutaneous closure system based on a polyglycolic acid plug for achieving hemostasis.MATERIAL AND METHODSIn this study from 2011 to 2014, a percutaneous vascular closure system (ExoSeal) was used in 1000 patients (mean age 70.6 ± 10.2 years), using antegrade and retrograde techniques within the context of an angiographic intervention. The system was used in conjunction with transfemoral approaches with a sheath size of 6F. Post the intervention (on the following day and after 6 weeks), follow-up was conducted clinically and using color-coded duplex ultrasound.RESULTSImmediate hemostasis was achieved in 939/1000 patients (93.9%). In the remaining 61 cases, a correct positioning of the polyglycolic acid plug was not possible because of malfunctioning of the device, massive vascular wall calcifications, postoperative scar tissue, or too steep a puncture angle. In these cases, manual compression was successful. There was one retroperitoneal bleeding requiring transfusion. Minor complications were observed (7.4% in total) with 10 pseudoaneurysm (1%), 63 inguinal hematomas (up to 3 cm; 6.3%), and 1 stenosis (0.1%).CONCLUSIONSafe and effective hemostasis is possible with the percutaneous ExoSeal closure system at puncture sizes of 6F.

show abstract

The StarClose Vascular Closure Device in Antegrade and Retrograde Punctures: A Single-Center Experience

Cited by 20 publications

References 8 publications

Safety and Efficacy of the StarClose Vascular Closure Device in More Than 1000 Consecutive Peripheral Angioplasty Procedures

Safety and Efficacy of the StarClose Vascular Closure Device in More Than 1000 Consecutive Peripheral Angioplasty Procedures

Safety and Efficacy of the StarClose Vascular Closure System following 8-Fr Sheath Placement for Intra-Aortic Balloon Pump: A Single-Center Analysis of 42 Consecutive Patients

Percutaneous Vascular Closure System Based on an Extravascular, Bioabsorbable Polyglycolic Plug (ExoSeal): Results from 1000 Patients

Contact Info

Product

Resources

About